Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 258

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 258
---
, 2022, with an effective date of June10, 2022. The parties held an update call with representatives of Profusa management, NorthView management, HCW and I -BankersSecurities on or about June15, 2022. •In addition to the Profusa LOI, NorthView entered into a second non -exclusiveletter of intent with Company A, effective as of June10, 2022. •On June16, 2022, Tungsten initiated a weekly update call including the CEO of Company A, representatives of I -Bankers, two representatives of Tungsten and NorthView management. •On June23, 2022, a list of updated documents in the Profusa virtual data room was presented to NorthView. The virtual data room was populated with, among other things, documents relating to Profusa’s organizational structure, governing documents, historical financial statements and material contracts. The NorthView team and its legal representatives at ArentFox Schiff LLP continued to conduct diligence on Profusa’s business including its financial outlook, product roadmap, patent strategy, technology platform, and clinical programs and progress, as well as pending product approvals, marketing channels, investor agreements and growth initiatives. •On June24, 2022, Profusa provided Northview with the Initial Projections. The Initial Projections were prepared solely by management of Profusa. See “ Opinion of Marshall & Stevens — Initial Financial Projections” for more information. •On June29, 2022, an internal evaluation was made by the NorthView team which identified Profusa as its lead target candidate for a business combination. On June30, NorthView had a call with Marshall & Stevens to discuss a possible fairness opinion and to get clarity on the process and timing for such an opinion. •On June30, 2022, Tungsten, I -Bankers, NorthView and management of Company A participated in a weekly call to discuss progress. On July1, 2022, two calls were taken the first with management of NorthView and Profusa and included HCW. Later that day an update call was held between the management of NorthView and I -Bankerswho represent NorthView. 128 •On July2, 2022, NorthView verbally authorized Marshall & Stevens to proceed with a multi -phasepreliminary valuation of potential targets and a full fairness analysis of Profusa. Marshall & Stevens’ analyses were expected to be performed using three accepted methodologies i.e., a cost approach, an